Serum levels of YKL-40 increases in patients with acute myocardial infarction

Camilla Nøjgaard; Nis B Høst; Ib Jarle Christensen; Steen Hvitfeldt Poulsen; Kenneth Egstrup; Paul A Price; Julia S Johansen

doi:10.1097/MCA.0b013e3282f40dd5

Serum levels of YKL-40 increases in patients with acute myocardial infarction

Camilla Nøjgaard, Nis B Høst, Ib Jarle Christensen, Steen Hvitfeldt Poulsen, Kenneth Egstrup, Paul A Price, Julia S Johansen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

82 Citationer (Scopus)

Abstract

YKL-40 is secreted by macrophages, including those in atherosclerotic plaques, neutrophils, and vascular smooth muscle cells. Circulating YKL-40 is elevated in patients with inflammation and increased tissue remodeling. The aim was to examine the sequential changes in serum YKL-40 in patients with acute myocardial infarction (AMI), with and without thrombolytic therapy, as compared with patients with stable coronary artery disease (CAD).

Originalsprog	Engelsk
Tidsskrift	Coronary Artery Disease
Vol/bind	19
Udgave nummer	4
Sider (fra-til)	257-63
Antal sider	7
ISSN	0954-6928
DOI	https://doi.org/10.1097/MCA.0b013e3282f40dd5 https://doi.org/10.1097/MCA.0b013e3282f40dd5
Status	Udgivet - 2008

Adgang til dokumentet

Citationsformater

@article{2d19d48001a611deb05e000ea68e967b,

title = "Serum levels of YKL-40 increases in patients with acute myocardial infarction",

abstract = "YKL-40 is secreted by macrophages, including those in atherosclerotic plaques, neutrophils, and vascular smooth muscle cells. Circulating YKL-40 is elevated in patients with inflammation and increased tissue remodeling. The aim was to examine the sequential changes in serum YKL-40 in patients with acute myocardial infarction (AMI), with and without thrombolytic therapy, as compared with patients with stable coronary artery disease (CAD).",

author = "Camilla N{\o}jgaard and H{\o}st, {Nis B} and Christensen, {Ib Jarle} and Poulsen, {Steen Hvitfeldt} and Kenneth Egstrup and Price, {Paul A} and Johansen, {Julia S}",

year = "2008",

doi = "10.1097/MCA.0b013e3282f40dd5",

language = "English",

volume = "19",

pages = "257--63",

journal = "Coronary Artery Disease",

issn = "0954-6928",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

TY - JOUR

T1 - Serum levels of YKL-40 increases in patients with acute myocardial infarction

AU - Nøjgaard, Camilla

AU - Høst, Nis B

AU - Christensen, Ib Jarle

AU - Poulsen, Steen Hvitfeldt

AU - Egstrup, Kenneth

AU - Price, Paul A

AU - Johansen, Julia S

PY - 2008

Y1 - 2008

N2 - YKL-40 is secreted by macrophages, including those in atherosclerotic plaques, neutrophils, and vascular smooth muscle cells. Circulating YKL-40 is elevated in patients with inflammation and increased tissue remodeling. The aim was to examine the sequential changes in serum YKL-40 in patients with acute myocardial infarction (AMI), with and without thrombolytic therapy, as compared with patients with stable coronary artery disease (CAD).

AB - YKL-40 is secreted by macrophages, including those in atherosclerotic plaques, neutrophils, and vascular smooth muscle cells. Circulating YKL-40 is elevated in patients with inflammation and increased tissue remodeling. The aim was to examine the sequential changes in serum YKL-40 in patients with acute myocardial infarction (AMI), with and without thrombolytic therapy, as compared with patients with stable coronary artery disease (CAD).

U2 - 10.1097/MCA.0b013e3282f40dd5

DO - 10.1097/MCA.0b013e3282f40dd5

M3 - Journal article

SN - 0954-6928

VL - 19

SP - 257

EP - 263

JO - Coronary Artery Disease

JF - Coronary Artery Disease

IS - 4

ER -